DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition

E-ISSN： 1875-5607|1|1|31-41

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.1, Iss.1, 2001-05, pp. : 31-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA targeting of two new antitumour rebeccamycin derivatives

By Facompre M. Baldeyrou B. Bailly C. Anizon F. Marminon C. Prudhomme M. Colson P. Houssier C.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 12, 2002-12 ,pp. : 925-932

Elsevier

Access to resources Recommend Favorite

Dialkylaminoalkylindolonaphthyridines as potential antitumour agents: synthesis, cytotoxicity and DNA binding properties

By Dalla Via L. Gia O. Marciani Magno S. Da Settimo A. Primofiore G. Da Settimo F. Simorini F. Marini A.M.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 6, 2002-06 ,pp. : 475-486

Elsevier

Access to resources Recommend Favorite

Telomerase Inhibition and Cancer: Might Platinum Based Drugs have a Future as Anti-telomerase Pharmacological Approach?

Current Medicinal Chemistry, Vol. 12, Iss. 26, 2005-12 ,pp. : 3091-3102

Bentham Science Publishers

Access to resources Recommend Favorite

Dynamics and Structure-based Design of Drugs Targeting the Critical Serine Protease of the Hepatitis C Virus - From a Peptidic Substrate to BILN 2061

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 111-132

Bentham Science Publishers

Access to resources Recommend Favorite

Development of distamycin-related DNA binding anticancer drugs

By Marchini Sergio Broggini Massimo Sessa Cristiana D’Incalci Maurizio

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1703-1714

Informa Healthcare

Access to resources Recommend Favorite